Journalists

Journalists

Covering current events in science, the environment, technology and health requires a context and reliable sources that respond quickly.

¿Qué me ofrece?

When science hits the headlines, we publish reactions, explanations, and in-depth analysis from reliable sources, capturing both the evidence and the debates. Our library of science journalism resources and the briefings may be of use to you. Consult our directory of research centres.

Icono
Cómo trabajamos

We are on the lookout for any controversial information about science (embargoed or not), in order to react with the agility the media needs. Sign up to receive our embargoed contents, all under the Creative Commons licence. Find out more about how we work here.

Título qué me ofrece
What we offer you
Título cómo trabajamos
How we work

Reaction: Intensive agriculture is most responsible for Europe's bird declines

A study led by the University of Montpellier (France) and with the participation of CREAF has analysed the causes of the decline in bird populations in Europe. To do so, they have compiled data on 170 bird species in 28 countries, including Spain, over 37 years. The overall decline is 25 %, and the decline in populations in agricultural areas is around 60 %. The main cause in both cases, according to the research, is intensive agriculture, although climate change is also an important factor. The results are published in the journal PNAS.

0

Reactions: Phase 1 clinical trial tests personalised mRNA vaccines for pancreatic cancer

A phase 1 clinical trial has tested personalised mRNA vaccines against the most common type of pancreatic cancer with a particularly poor prognosis. The treatment, which is tailored to the characteristics of each patient's tumour, was given to 16 people along with surgery, chemotherapy and other immunotherapy. Half of them showed an immune response to the vaccine, which was associated with a better prognosis. The results are published in the journal Nature.

0

Reaction: study shows Alzheimer's drug lecanemab helps neutralise the effects of small toxic amyloid aggregates

Research led by scientists at Harvard Medical School (USA) has isolated small aggregates of amyloid from the brains of post-mortem Alzheimer's patients. The achievement has made it possible to study the structure of these "clumps", which exist outside plaques and are considered highly toxic, and to test their effect on synapses. In addition, the authors have shown that the drug lecanemab, recently approved by the FDA, is able to bind to them and help neutralise their action. The results are published in the journal Neuron.

0

Reactions: first draft of human pangenome published

In a series of three articles and a companion article - collected in Nature Biotechonology - Nature publishes the first draft of the human pangenome reference, which contains highly detailed data from 47 genetically diverse individuals. The first human genome was published more than two decades ago but, being from a single person, it does not represent human diversity, whereas the pangenome refers to the gene pool of our entire species. The ultimate goal of the Human Pangenome Reference Consortium project is to include genetic material from 350 people by 2024. It is hoped that this data will allow more clinically relevant genetic variants to be identified.

0

Reaction: Study says time spent on social media is one of the least influential factors in adolescent mental health

The time adolescents spend on social media is one of the least influential factors for their mental health, according to a study published in Nature Mental Health. The analysis attempts to untangle the complex web of risk factors and protective factors, using data from more than 12,000 young people in the UK. Among the factors studied, it concludes that bullying, lack of family support and school work dissatisfaction are more influential than time spent on social media. According to the study, life dissatisfaction and lack of family support are the most influential factors for girls and boys, respectively. 

0

Reactions: WHO declares end of international covid-19 emergency

The World Health Organisation (WHO) Emergency Committee met on 4 May to assess whether covid-19 could continue to be considered a health emergency of international concern (PHEIC). The organisation's director general, Tedros Adhanom, has followed its recommendation and ended the emergency declared on 30 January 2020. "It is with great hope that I declare that covid-19 has ended as a global health emergency. However, this does not mean that covid-19 is no longer a threat to global health. Last week, it claimed one life every three minutes, and that's just the deaths we know about," he told a press conference.

0

Reactions: Study attributes April's unusually high temperatures on the Iberian Peninsula to climate change

Climate change made the late April episode of record temperatures in the Iberian Peninsula, Morocco and Algeria 100 times more likely to occur, with temperatures up to 3.5°C higher than they would have been without the climate crisis. This is one of the conclusions of an attribution study conducted by World Weather Attribution.

0

Reactions: healthy lifestyle reduces risk of relapse and increases survival in patients with operable breast cancer

A study published in JAMA Network Open has followed 1,340 women with high-risk operable breast cancer. Analysing their lifestyles before, during and after treatment, the researchers conclude that those who followed a healthier pattern - including physical activity, no smoking, high fruit and vegetable intake, and low consumption of meat and sugary drinks - had a 37% lower risk of relapse and a 58% higher chance of survival than those who followed a worse pattern. Although the improvements in absolute risk were much smaller, the authors conclude that "lifestyle interventions may be a safe, inexpensive and feasible adjuvant strategy to delay and prevent recurrence and death from the world's most common cancer".

0

Reaction: stopping endocrine therapy to try to get pregnant after breast cancer does not worsen prognosis

A study published today in the NEJM examines the risk of relapse in breast cancer patients who decide to pause endocrine therapy to try to become pregnant. The results show that temporarily stopping treatment does not confer an increased risk in the long term, but the authors warn of the need for further follow-up.

0